IRF5 and hepatocellular carcinoma: In summary, our results show that SS inhibited growth of HepG2 HCC and QGY-7703 cells through the reciprocal regulation between the miR-375-3p and lncRNA CCAT1, which leads to transcription factor SP1-mediated reduction of IRF5 expression (Figure 6H).